Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
collaboration
MedTech
Oxford Nanopore, SeqOne ink rare disease diagnostic partnership
The goal will be to provide an end-to-end platform that applies extra-long nanopore sequencing reads to whole genomes.
Conor Hale
Mar 15, 2024 3:10pm
Merck bets up to $1B on Pearl's 'smart' biologics
Mar 12, 2024 8:00am
Eisai backs C2N's Alzheimer's blood tests with up to $15M
Mar 6, 2024 2:54pm
Merck KGaA paying $16M to join C4's protein degrader hunt
Mar 4, 2024 10:18am
AbbVie wraps up $64M oncology, immunology deal with Tentarix
Feb 22, 2024 9:09am
Everest to continue mRNA ascent alone, ending Providence collab
Feb 20, 2024 8:19am